Cleared Special

K163479 - R2P Metacross RX

K163479 is an FDA 510(k) clearance for R2P Metacross RX, manufactured by KANEKA Corporation. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Special 510(k) pathway after a 30-day FDA review.

K163479 · KANEKA Corporation · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2017
Decision
30d
Days
Class 2
Risk

K163479 is an FDA 510(k) clearance for the R2P Metacross RX. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by KANEKA Corporation (Tokyo, JP). The FDA issued a Cleared decision on January 11, 2017 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all KANEKA Corporation devices

FDA 510(k) Submission Details - K163479

510(k) Number K163479 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2016
Decision Date January 11, 2017
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Quintiles Consulting
CHRISTOPHER M. SLOAN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 374
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K163479.
Chameleon PTA Balloon Catheter
K170635 · Av Medical Technologies, Ltd. · Mar 2017
Advance 14LP Low Profile PTA Balloon Dilatation Catheter
K170193 · Cook Incorporated · Feb 2017
Chameleon PTA Balloon Catheter
K163231 · Av Medical Technologies, Ltd. · Jan 2017
Castor, Achilles and Hermes NC PTA Balloon Dilatation Catheter
K160941 · Brosmed Medical Co., Ltd. · Dec 2016
Pirouette 014
K162316 · Arravasc, Ltd. · Nov 2016
Coyote Monorail Percutaneous Transluminal Angioplasty Balloon Dilatation Catheter, Express SD Biliary Monorail Premounted Stent System, Maverick XL Percutaneous Transluminal Coronary Angioplasty Monorail Dilatation Catheter, Sterling Monorail Percutaneous Transluminal Angioplasty Balloon Dilatation Catheter, Ultra-Soft SV Monorail Balloon Dilatation Catheter 0.018
K162350 · Boston Scientific Corporation · Nov 2016